Sylvie Murgo

Sylvie Murgo has extensive experience as an IP Director, starting in 2006 with Fovea Pharmaceuticals and Transgene where they worked until 2010 and 2013 respectively. Since then, they have held the same role at various companies including GenSight Biologics, Pixium Vision S.A., Gecko Biomedical, BrainEver, PROPHESEE, Tilak Healthcare, Chronolife, and iBionext.

Sylvie Murgo began their education at Strasbourg University in 1986 and completed their studies in 1991, earning a Doctor of Philosophy (PhD) in Biochemistry and Molecular Biology. Sylvie then pursued further education at CEIPI between 1992 and 1993, however, the degree name and field of study during that time are not provided.